These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 1847022
1. Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats. Chiu PJ, Tetzloff G, Romano MT, Foster CJ, Sybertz EJ. Am J Physiol; 1991 Jan; 260(1 Pt 2):R208-16. PubMed ID: 1847022 [Abstract] [Full Text] [Related]
2. The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade. Barclay PL, Bennett JA, Greengrass PM, Griffin A, Samuels GM, Shepperson NB. Biochem Pharmacol; 1992 Sep 25; 44(6):1013-22. PubMed ID: 1417928 [Abstract] [Full Text] [Related]
3. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand. Kukkonen P, Vuolteenaho O, Ruskoaho H. Endocrinology; 1992 Feb 25; 130(2):755-65. PubMed ID: 1531129 [Abstract] [Full Text] [Related]
4. Clearance function of type C receptors of atrial natriuretic factor in rats. Almeida FA, Suzuki M, Scarborough RM, Lewicki JA, Maack T. Am J Physiol; 1989 Feb 25; 256(2 Pt 2):R469-75. PubMed ID: 2537040 [Abstract] [Full Text] [Related]
5. Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition. Abassi ZA, Tate J, Hunsberger S, Klein H, Trachewsky D, Keiser HR. Am J Physiol; 1992 Nov 25; 263(5 Pt 1):E870-6. PubMed ID: 1443119 [Abstract] [Full Text] [Related]
6. Clearance receptor and neutral endopeptidase-mediated metabolism of atrial natriuretic factor. Okolicany J, McEnroe GA, Koh GY, Lewicki JA, Maack T. Am J Physiol; 1992 Sep 25; 263(3 Pt 2):F546-53. PubMed ID: 1415584 [Abstract] [Full Text] [Related]
7. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats. Sybertz EJ, Chiu PJ, Vemulapalli S, Pitts B, Foster CJ, Watkins RW, Barnett A, Haslanger MF. J Pharmacol Exp Ther; 1989 Aug 25; 250(2):624-31. PubMed ID: 2547941 [Abstract] [Full Text] [Related]
12. Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit. Marleau S, Nguyen TT, Du Souich P, Bellemare M, De Lean A, Ong H. Drug Metab Dispos; 1991 Aug 25; 19(1):194-9. PubMed ID: 1673398 [Abstract] [Full Text] [Related]
13. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors. Seymour AA, Norman JA, Asaad MM, Fennell SA, Abboa-Offei B, Little DK, Kratunis VJ, Delaney NG, Hunt JT, Di Donato G. J Pharmacol Exp Ther; 1991 Mar 25; 256(3):1002-9. PubMed ID: 1826031 [Abstract] [Full Text] [Related]